Australian Clinical Trials
Clinical Trials Related to EB in Australia
The following clinical trials in EB are currently active in Australia. Anyone who is interested is encouraged to contact one of the study centres to obtain more information about the trial.
Trial | Status | Links for More Information |
---|---|---|
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) | Recruiting | ANZCTR – Registration For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT06073132More information here. |
Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE) | Study Closed | https://clinicaltrials.gov
Study identifier NCT03068780 |
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study | Study Closed | https://clinicaltrials.gov
Study identifier NCT03016715 |
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) | Study Closed | https://clinicaltrials.gov
Study identifier: NCT03154333 Study Language for Patient Advocacy Website: http://www.deliversebs.com |